Latest Announcements

BSE & NSE corporate filings with AI summaries

BSECompany Update▲ PositiveResults5d ago

SMS Pharmaceuticals Ltd

Earnings Call Transcript

SMS Pharmaceuticals Ltd announced its Q2 and H1 FY27 earnings, with revenue growth of 30% and 19% respectively, driven by higher volumes and improved price realization. Gross profit and EBITDA margins expanded, with PAT growing 57% and 36% respectively.

Read more →📎 1 attachment
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults5d ago

SMS Pharmaceuticals Limited

Analysts/Institutional Investor Meet/Con. Call Updates

SMS Pharmaceuticals Limited has announced its Q2 and H1 FY27 earnings, with revenue growing 30% year-on-year to INR316 crores, driven by higher volumes, improved price realization, and continued growth across its product portfolio. Gross profit rose 41% to INR111 crores, and EBITDA stood at INR68 crores, a growth of 40% with margins expanding 145 basis points to 21%. PAT grew 57% to INR39.6 crores, a PAT margin of approximately 13%. The company has maintained its growth momentum and delivered a strong operational and financial performance.

Read more →📎 1 attachment
BSECompany UpdateResults5d ago

Premier Energies Ltd

Monitoring Agency Report

Premier Energies Ltd submitted a Monitoring Agency Report to BSE, as per Regulation 41 of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, and Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The report pertains to the utilization of the proceeds of the Initial Public Offer (IPO) for the quarter ended September 30, 2026.

Read more →📎 1 attachment
NSECredit Rating▲ PositiveRating Change5d ago

Adani Power Limited

Credit Rating

Adani Power Limited has informed the Exchange about Credit Rating upgrade by ICRA Limited to AA+ (Stable) from AA (Stable) for various facilities, citing sustained operational robustness and financial strength, as well as expected capacity additions from ongoing projects.

Read more →📎 1 attachment
NSEAnalysts/Institutional Investor Meet/Con. Call Updates5d ago

Delhivery Limited

Analysts/Institutional Investor Meet/Con. Call Updates

Delhivery Limited has informed the Exchange about a Schedule of Investors Conference, to be held on November 16, 2026, in Mumbai. The meeting will be attended by the company's representatives and will discuss general business outlook and information already in the public domain.

Read more →📎 1 attachment
NSEPress Release▲ PositiveFundraise5d ago

IIFL Finance Limited

Press Release

IIFL Finance Limited has announced a primary private equity infusion of ₹6,414 Crores ($686 million) led by Blackstone and the promoters, with Blackstone investing ₹5,000 crores ($535 million) and the promoters investing ₹1,264 crores ($135 million).

Read more →📎 1 attachment
NSEPress ReleaseESG5d ago

TVS Srichakra Limited

Press Release

TVS Srichakra Limited has released a Diwali film titled 'Worth the Wait' that explores a centuries-old Diwali custom in the village of Chilla, near Chandigarh. The film is available on YouTube and Eurogrip's social media channels.

Read more →📎 1 attachment
NSEOutcome of Board MeetingResults5d ago

ARSS Infrastructure Projects Limited

Outcome of Board Meeting

ARSS Infrastructure Projects Limited has submitted its financial results for the quarter and half year ended September 30, 2026. The company has increased its authorized share capital from ₹500 Crore to ₹1,100 Crore, comprising of ₹230 Crore divided into 23 Crore Equity Shares of ₹10/- each and ₹870 Crore divided into 87 Crore Preference Shares of ₹10/- each. The company has also announced material related party transactions with Ocean Capital Market Limited and Mr. Dipti Ranjan Patnaik, promoters, and plans to issue non-convertible redeemable preference shares to them on private placement basis. The company has also arranged for remote e-voting for the shareholders to approve the resolutions.

Read more →📎 1 attachment
BSECompany Update▲ PositiveFundraise5d ago

IIFL Finance Ltd

IIFL Finance Limited has informed the Exchanges regarding Press Release dated November 10, 2026.

IIFL Finance Ltd has announced a primary capital raise of ₹6,414 crores ($686 million) through a preferential issue, with Blackstone Private Equity investing ₹5,000 crores ($535 million) and the promoters investing ₹1,264 crores ($135 million). The funds will strengthen the company's capital adequacy, improve its cost of funds, and accelerate growth in its gold finance business.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults5d ago

Alembic Pharmaceuticals Ltd

Please find attached herewith the Transcript of Post Results Conference Call held on 4th November, 2026.

Alembic Pharmaceuticals Ltd's Q2 and H1 FY27 earnings conference call highlights strong performances across all businesses, with consolidated revenue growing 36% Y-on-Y. The India business delivered a 14% year-on-year growth, led by Human Health, while the U.S. Generics business saw exceptional growth with revenue increasing 72% Y-on-Y. The company also announced an expanded strategic collaboration with DifGen Pharmaceuticals.

Read more →📎 1 attachment
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults5d ago

Alembic Pharmaceuticals Limited

Analysts/Institutional Investor Meet/Con. Call Updates

Alembic Pharmaceuticals Limited held an earnings conference call for Q2 and H1 FY27, with a consolidated revenue growth of 36% Y-on-Y. The company's India business delivered a 14% year-on-year growth, driven by strong performances in Human Health and Animal Health. The U.S. Generics business showed exceptional growth with revenue increasing by 72% year-on-year. The company also announced an expansion of its strategic collaboration with DifGen Pharmaceuticals, giving access to a differentiated portfolio of over 20 products.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults5d ago

Ind-Swift Laboratories Ltd

Please find enclosed transcript for earnings call held on November 04, 2026.

Ind-Swift Laboratories Ltd has announced its Q2 FY27 earnings, with a 50.15% year-on-year increase in operating revenue to ₹234.89 crore. The company's operating EBITDA rose 4.95x year-on-year to ₹42.33 crore, and the operating EBITDA margin expanded 1,256 basis points to 18.02%. The PAT surged 3.54x year-on-year to ₹31.03 crore, delivering a PAT margin of 13.21%. The company's H1 FY27 performance also saw a 35.79% year-on-year increase in operating revenue to ₹420.97 crore, with operating EBITDA surging 4.45 times to ₹75.65 crore and EBITDA margin expanding by 1,254 basis points to 17.97%. The company's export footprint remains the primary growth engine, with 82.7% of total sales, while domestic verticals continue to provide steady cash flow stability with 17.3% of total sales.

Read more →📎 1 attachment
← PreviousPage 764 of 15732Next →